Stefania Boccia

This study examines gender differences in retraction rates among highly cited and all authors, finding no major gender disparities but field-specific variations.

This study reviews RCTs on polygenic risk score communication, finding no significant effects on health outcomes despite frequent positive claims.

This study examines the use of genetic and other omics information in highly cited clinical trials, finding that 22% of trials used such data, mostly in oncology, with significant industry involvement and limited transparency.

Linking 39,468 eligible Retraction Watch retractions to Scopus shows 3.3% of 217,097 career-long and 4.0% of 223,152 single-year (2023) top-2% cited scientists have at least one retraction.

This study uses Mendelian randomization to assess the causal effect of sexual behavior on oropharyngeal cancer risk, finding attenuated associations after adjusting for confounders.

This study quantifies genetic correlations between six solid cancers and other diseases using GWAS data, finding shared heritability and functional enrichment in regulatory regions.